[1]
A. Das, S. Banerjee, and K. Kumar Sen, “Design and discovery of some novel protease inhibitors against SARS-CoV-2 main protease by molecular docking, drug-likeness and ADME studies: An in-silico approach: Discovery of novel protease inhibitors against 2019 nCoV”, Int Pharm Acta, vol. 4, no. 1, pp. 4e9:1–13, Aug. 2021.